Name: Exploring the Role of Clinical-Grade Augmented Intelligence in Enhancing Health Care Data Management by Population Health Learning Network
Duration: 23 min 45 s
Description: In this interview, Dr Colin Banas, Chief Medical Officer for DrFirst, discusses the challenges in health care data management, the importance of semantic interoperability, and how clinical-grade AI can improve medication safety and patient outcomes.

Addressing Prescription Drug Pricing: Fixing an Unsustainable Situation

Expert Insights into Value-Based Care for Polymyalgia Rheumatica

In this interview, Dr Colin Banas, Chief Medical Officer for DrFirst, discusses the challenges in health care data management, the importance of semantic interoperability, and how clinical-grade AI can improve medication safety and patient outcomes.

Exploring the Role of Clinical-Grade Augmented Intelligence in Enhancing Health Care Data Management

In this episode, Dr Gary Owens explores the reasons behind lower vaccine adherence among immunocompromised patients and compares the efficacy of mRNA-1273 and BNT162b2 vaccines for this population, offering insights into factors to consider when choosing between the two.

Efficacy Differences, Adherence Challenges Between COVID-19 Vaccines

Discover how digital therapeutics are revolutionizing disease management, patient care, reducing health care costs, and more with Dr Mansur Shomali, CMO at Welldoc.

Expanding Diabetes Care Through Digital Therapeutics

Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates Consultant Yash Prajapati.

Standardizing the Field of Digital Medicine: Insights from an Industry Expert

Health care cybersecurity is an increasing priority as cyber criminals’ tactics become more sophisticated and data breaches can erode patient trust and jeopardize patient safety.

The Impact of Data Theft on Patient Care: Insights from a Health Care Cybersecurity Professional

Petros Grivas, MD, PhD, discusses the combination of sacituzumab govetican and pembrolizumab for metastatic urothelial carcinoma in the second-line setting.

Sacituzumab Govitecan Plus Pembrolizumab in the TROPHY-U-01 Trial

Join us as guest expert Gary Owens discusses how formulary exclusions can impact patient medication adherence and lead to adverse economic outcomes, making the need for non-medical switching and formulary exception requests an important issue for both patients and health care providers.

Understanding the Impact of Formulary Exclusions on Medication Adherence

Dania Daye, MD, PhD, joins the SIO Corner podcast to discuss the ways AI may be applied in interventional oncology.

Exploring the Role of Clinical-Grade Augmented Intelligence in Enhancing Health Care Data Management

Population Health Learning Network

Related tracks